Neurotrophic Factors in the Pathogenesis of Rett Syndrome

Abstract

Rett syndrome is characterized by disruption of a period of vigorous brain growth with synapse development. Neurotrophic factors are important regulators of neuronal growth, differentiation, and survival during early brain development. The aims of this study were to study the role of neurotrophic factors in Rett syndrome, specifically whether Rett syndrome has abnormal levels of specific neurotrophic factors in serum and cerebrospinal fluid and whether the changes differ from other neuropediatric patients, for example, those with infantile autism. Four neurotrophic factors were measured: nerve growth factor, brain-derived neurotrophic factor, glial cell line—derived neurotrophic factor, and insulin-like growth factor 1 from the frozen cerebrospinal fluid and from serum (except glial cell line—derived neurotrophic factor) by enzyme-linked immunosorbent assay and cerebrospinal fluid glutamate and aspartate by high-performance liquid chromatography (HPLC) method in patients with Rett syndrome. Insulin-like growth factor 1 was measured from the cerebrospinal fluid of patients with infantile autism. We found low concentrations of cerebrospinal fluid nerve growth factor in patients with Rett syndrome compared with control patients. The serum levels and other cerebrospinal fluid neurotrophic factor levels of the patients did not differ from the controls. Patients with Rett syndrome had high cerebrospinal fluid glutamate levels. Patients with infantile autism had low cerebrospinal fluid insulin-like growth factor 1 levels. Nerve growth factor acts especially on cholinergic neurons of the basal forebrain, whereas insulin-like growth factor 1 acts on cerebellar neurons. In Rett syndrome, the forebrain is more severely affected than the other cortical areas. In autism, many studies show hippocampal or cerebellar pathology. Our findings are in agreement with the different morphologic and neurochemical findings (brain growth, affected brain areas, neurotransmitter metabolism) in the two syndromes. Impairment in dendritic development in Rett syndrome could be the consequence of cholinergic deficiency and of neurotrophic factor/glutamate imbalance. Cholinergic gene expression might be influenced by the Rett syndrome gene directly or via the neurotrophic factor system. (J Child Neurol 2003;18:693—697).

Get full access to this article

View all access options for this article.

References

Armstrong D. , Dunn J. , Antalffy B. , Trivedi R. : Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 1995;54:195—201.

Percy A. : Neurobiology and neurochemistry of Rett syndrome. Eur Child Adolesc Psychiatry 1997;6:80—82.

Belincho P. , Hagberg B. : Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol (Berl) 1997;93:50—61.

Johnston M. , Jeon O. , Pevsner J. , et al: Neurobiology of Rett syndrome: A genetic disorder of synapse development. Brain Dev 2001;23(Suppl 1):S206—S213.

Ebendal T. : Function and evolution in the NGF family and its receptors. J Neurosci Res 1992;32:461—470.

Sofroniew M. , Cooper J. : Neurotrophic mechanisms and neuronal degeneration . Neuroscience 1993;5:285—294.

Auranen M. , Vanhala R. , Vosman M. , et al: MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features. Neurology 2001;56:611—617.

Lappalainen R. , Lindholm D. , Riikonen R. : Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome. J Child Neurol 1996;11:296—300.

Riikonen R. , Vanhala R. : Levels of cerebrospinal nerve-growth factor differ in infantile autism and Rett syndrome. Dev Med Child Neurol 1999;41:148—152.

10.

Gillberg C. , Coleman M. : Autism and medical disorders: A review of the literature. Dev Med Child Neurol 1996;38:191—202.

11.

Lappalainen R. , Riikonen R. : High levels of cerebrospinal fluid glutamate in Rett syndrome. Pediatr Neurol 1996; 15: 213—216.

12.

Vanhala R. , Korhonen L. , Mikelsaar M. , et al: Neurotrophic factors in cerebrospinal fluid of patients with Rett syndrome. J Child Neurol 1998;13:429—433.

13.

Vanhala R. , Turpeinen U. , Riikonen R. : Low levels of insulin-like growth factor in cerebrospinal fluid in children with autism. Dev Med Child Neurol 2001;43:614—616.

14.

Hohmann C. , Brooks A. , Coyle J. : Neonatal lesions of the basal forebrain cholinergic neurons result in abnormal cortical development. Dev Brain Res 1988;43:253—264.

15.

Armstrong D. , Dunn J. , Schultz R. , et al: Organ growth in Rett syndrome; a postmortem examination and analysis. Pediatr Neurol 1999 ;20:125—129.

16.

Raymond G. , Bauman M. , Kemper T. : Hippocampus in autism: A Golgi analysis. Acta Neuropathol (Berl) 1996;91:117—119.

17.

Wenk GL , Hauss-Wegrzyniak B. : Altered cholinergic function in the basal forebrain of girls with Rett syndrome . Neuropediatrics 1999;30:125—129.

18.

Lipani JD , Bhattacharjee MB , Corey DM , Lee DA : Reduced nerve growth factor in Rett syndrome postmortem brain tissue. J Neuropathol Exp Neurol 2000;59:889—895.

19.

Uvebrandt P. , Bjure J. , Sixt R. , et al: Regional cerebral blood flow: SPECT as a tool for localization of brain dysfunction, in Hagberg B (ed): Rett Syndrome—Clinical and Biological Aspects. London, Mac Keith Press, 1993, 80—85.

20.

Lappalainen R. , Liewendahl K. , Sainio K. , Riikonen R. : Brain perfusion SPECT and EEG findings in Rett syndrome. Acta Paediatr Scand 1997;95:44—50.

21.

Leventhal P. , Russell J. , Feldman E. : IgFs and the nervous system, in Rosenfeld R , Roberts C (eds): The IGF System: Molecular Biology, Physiology, and Clinical Application. Totawa, NJ, Humana Press, 1999, 425—455.

22.

Torres-Aleman I. , Poins S. , Santos-Benito F. : Survival of Purkinje cells in cerebellar cultures increased by insulin-like growth factor-1. Eur J Neurosci 1992;4:864—869.

23.

Torres-Aleman I. , Barrios V. , Lledo A. , Berciano J. : The insulin-like growth factor-1 modulation of cerebellar cell populations is developmentally stage-dependent and mediated by specific intracellular pathways. Neuroscience 1998;83:321—334.

24.

Gao W. , Heintz N. , Hatten M. : Cerebellar granule neurogenesis is regulated by cell-cell interaction in vitro . Neuron 1991;6:705—715.

25.

Courchesne E. , Yeung-Courchesne R. , Press GA , et al: Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med 1988;318:1349—1354.

26.

Hashimoto T. , Tayama M. , Murakawa K. , et al: Development of brain-stem and cerebellum in autistic patients. J Autism Dev Disord 1995;25:1—18.

27.

Rapin I. , Katzman R. : Neurobiology of autism. Ann Neurol 1998;43:7—14.

28.

Bauman M. , Kemper T. : Histoanatomic observations of the brain in early infantile autism. Neurology 1985;35:862—866.

29.

Riikonen R. , Somer M. , Turpeinen U. : Low insulin-like growth factor (IGF-1) in the cerebrospinal fluid of children with PEHO syndrome (progressive encephalopathy, hypsarrhythmia and optic atrophy) and cerebellar degeneration. Epilepsia 1999;40: 1642—1648.

30.

Davidovitch M. , Patterson B. , Gartside P. : Head circumference measurements in children with autism. J Child Neurol 1996; 11:389—393.

31.

Sparks B. , Friedman S. , Shaw D. , et al: Brain structural abnormalities in young children with autism spectrum disorder. Neurology 2002;59:184—192.

32.

Coleman P. , Romano J. , Lapham I. , Simon W. : Cell counts in cerebral cortex in autistic patient. J Autism Dev Disord 1985;15: 245—255.

33.

Anderson G. , Freedman D. , Cohen D. , et al: Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 1987;28:885—900.

34.

Chugani H. , Muzik O. , Rothermel R. , et al: Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 1997;42:666—669.

35.

Cook E. , Courchesne R. , Lord C. , et al: Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997;2:247—250.

36.

Rodier P. , Ingram J. , Tisdale B. , et al: Embryological origin for autism; developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 1996;370:247—261.

37.

Monaghan D. , Bridges R. , Cotman C. : The excitatory amino acid receptors. Annu Rev Pharmacol Toxicol 1989;29:365—402.

38.

Rothman S. , Olney J. : Excitotoxicity and NMDA receptor. Trends Neurosci 1987;10:299—302.

39.

Ikonomidou C. , Turski L. : Excitotoxicity and neurodegenerative diseases . Curr Opin Neurol 1995;8:487—497.

40.

Lindholm D. : Role of neurotrophins in preventing glutamate induced neuronal cell death. J Neurol 1994 ;24(Suppl 1):S16—S18.

41.

Riikonen R. , Korhonen L. , Lindholm D. : Cerebrospinal fluid growth factor — A marker of asphyxia? Pediatr Neurol 1999; 20: 137—141.

42.

Riikonen R. , Söderström S. , Vanhala R. , et al: West syndrome: Cerebrospinal fluid nerve growth factor and effect of ACTH. Pediatr Neurol 1997;17:224—229.